Latest Breaking News On - Sriram ramanathan - Page 1 : vimarsana.com

Exela Technologies and XBP Europe Announce the Launch of Reaktr.ai to Provide Cybersecurity, Data Modernization and Multi-Cloud Management Enabled by AI

Exela Technologies and XBP Europe Announce the Launch of Reaktr.ai to Provide Cybersecurity, ...

IRVING, Texas and LONDON, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA, XELAP) and XBP Europe (“XBP”) (NASDAQ: XBP, XBPEW) announce the launch

Exela Technologies and XBP Europe Announce the Launch of Reaktr.ai to Provide Cybersecurity, Data Modernization and Multi-Cloud Management Enabled by AI

Exela Technologies Leverages Generative AI with Microsoft Azure OpenAI Service

Exela Technologies, Inc.: Exela Technologies Leverages Generative AI with Microsoft Azure OpenAI Service

What's Going On With Exela Technologies Stock Today? - Exela Technologies (NASDAQ:XELA)

Exela Technologies, Inc. (NASDAQ: XELA) shares are trading lower Thursday.

FDA Approves Ready-to-Dilute Cyclophosphamide Injection for Various Cancers

The FDA has approved a new drug application for 200-mg/mL vials of cyclophosphamide injection for use in combination therapy in the treatment of patients with various types of cancers, including malignant lymphoma, multiple myeloma, and various types of leukemia.

Nevakar Injectables Announces FDA Approval of Cyclophosphamide RTD Solution

Exela Technologies Announces Generative AI Initiatives

Long Grove Pharmaceuticals Secures Commercial Rights to an Essential Critical Care Medication

/PRNewswire/ -- Long Grove Pharmaceuticals announced the strategic in-licensing of Norepinephrine in 0.9% Sodium Chloride premix formulation from Nevakar...